The Food and Drug Administration has approved the world’s first medicine based on CRISPR gene-editing technology, a ...

The agreement allows EditCo to integrate Promega's HiBiT, HaloTag, and NanoLuc protein tagging tech with its knock-in gene ...

Scientists and policymakers are meeting in Washington, DC December 1-3 to debate the use of CRISPR/Cas9, a tool that makes it possible to make changes to an organism's DNA almost as easily as ...

The medical promise of CRISPR gene editing can be seen most easily in current research on oral cancer, which affects more than 50,000 Americans every year. An increasing challenge in the treatment ...

Researchers have developed a novel method using CRISPR to study transcription factors affecting blood cell development. The Perturb-multiome approach identifies critical DNA regions linked to blood ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

What are NGTs, how do they differ from GMOs and how are they agriculturally applied and regulated in the EU? View on euronews ...

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

CRISPR Therapeutics won its first regulatory approval a little over a year ago, and has compelling candidates in the pipeline. Of course, Vertex's success didn't happen overnight -- and the ...

KSQ-004EX is being evaluated in solid tumors including melanoma, non-small cell lung, head and neck, colorectal, pancreatic ...